ReviewCancers2026

First-Line Chemotherapy Regimens for Advanced and Metastatic Leiomyosarcoma: Doxorubicin vs. Gemcitabine-A Systematic Review.

Ilma Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.